维普中文期刊产品整合服务
17篇 您的检索式:作者名="Danesh F R"
    题名 作者 年代 出处 被引量
1胆固醇酯转移蛋白基因的蛋白质截断型变异体与冠状动脉性心脏病风险的关系显示文摘随机对照试验结果表明,抑制胆固醇酯转运蛋白(cholesteryl ester transfer protein,CETP)的疗法并不能降低冠状动脉性心脏病(coronary heart disease,CHD)的发生风险。研究失败的可能原因包括靶目标无效、靶目标外小分子的不良反应和随机对照设计因素影响等。在编码药物靶点的基因中具有天然存在的遗传变异,以此为基础,人类研究可以深入了解针对基因产物的治疗的潜在功效和安全性。Nomura A Won HH Khera AV Takeuchi F Ito K McCarthy S Emdin CA Klarin D Natarajan P Zekavat SM Gupta N Peloso GM Borecki IB Teslovich TM Asselta R Duga S Merlini PA Correa A Kessler T Wilson JG Bown MJ Hall AS Braund PS Carey DJ Murray MF Kirchner HL Leader JB Lavage DR Manus JN Hartze DN Samani NJ Schunkert H Marrugat J Elosua R McPherson R Farrall M Watkins H Juang JJ Hsiung CA Lin SY Wang JS Tada H Kawashiri MA Inazu A Yamagishi M Katsuya T Nakashima E Nakatochi M Yamamoto K Yokota M Momozawa Y Rotter JI Lander ES Rader DJ Danesh J Ardissino D Gabriel S Willer CJ Abecasis GR Saleheen D Kubo M Kato N Ida Chen YD Dewey FE Kathiresan S 刘莉 叶鹏 2017中华高血压杂志2017,25,9:2
2Digestion of feed amino acids in the rumen and intestine of steers measured using a mobile nylon bag technique显示文摘Taghizadeh A Danesh Mesgaran M Valizadeh R Eftekhar Shahroodi F Stanford K 2005Journal of Dairy Science2005,88,5:1
33 Hydroxy-3 - methyl - glutaryl CoA reduetase inhibitors prevent high gluoouse - induced proliferation of mesangial cells via modulation of Rho GI- Pase/p21 signaling pathway: Implications for diabetic nephropathy 显示文摘DANESH F R SADEGHI M M AMMO N 2002Prec Natl Acad Sci2002,11,99:1
4Effects of statin therapy on the progression of chronic kidney disease 显示文摘Shah S Paparello J Danesh F R 2005Adv Chronic Kidney Dis2005,12,2:1
53-Hydroxy3methylglutaryl COA reductase inhibitors prevent high glucose-induced proliferation of mesangial calls via modulation of Rho GTPase/P21 signaling pathway显示文摘Danesh F R Sadeghi M M Amro N 2002Pro Natl Acad Sci USA2002,99,12:1
6Effects of statin the rapy on the progression of chronic kidney disease显示文摘Shah S Paparello J Danesh F R 2005Adv Chronic Kidney Dis2005,12,2:1
7Modulatory effects of HMG-CoA reductase inhibitors in diabetic mieroangiopathy 显示文摘Danesh F R Kanwar Y S 2004FASEB J2004,18,7:1
8Effects of statin therapy on the progression of chronic kidney disease显示文摘SHAH S PAPARELLO J DANESH F R 2005Adv Chronic Kidney Dis2005,12,2:1
9Lupus membranous glomerulonephritis mimicking hepatitis C-associated nephropathy显示文摘 Lynch P Kanwar Y S 2002Am J Kidney Dis2002,39,3:1
10Effects of stain therapy on the progression of chronic kidney disease显示文摘Shah S Paparello J Danesh F R 2005Adv Chronic Kidney Dis2005,12,2:1
11Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy 显示文摘Danesh F R Kanwar Y S 2004FASEB Journal2004,18,7:1
12New insights into molecular mechanisms of diabetic kidney disease 显示文摘Badal S S Danesh F R 2014Am J Kidney Dis2014,63,2:1
133-Hydroxy-3methylglutaryl COA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/P21 signaling pathway显示文摘Danesh F R Sadeghi M M Amro N 2002Pro Natl Acad Sci USA2002,99,12:1
14Modulatory effects of HMG- CoA reductase inhibitors in diabetic microangiopathy 显示文摘DANESH F R KANWAR Y S 2004FASEB J2004,18,7:1
15Effects of statin the rapy on the progression of chronic kidney disease显示文摘Shah S Paparello J Danesh F R 2005Adv Chronic Kidney Dis2005,12,2:1
16Effects of statin therapy on the progression of chronic kidney disease显示文摘SHAH S PAPARELLO J DANESH F R 2005Adv Chronic Kidney Dis2005,12,:1
173-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/p21 signaling pathway:Implications for diabetic nephropathy显示文摘DANESH F R SADEGHI M M AMRO N 2002Proc Natl Acad Sci USA2002,99,15:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费